FMC's Board Approves Evaluation Of Strategic Options; Co. Targets Debt Reduction Of ~$1B In 2026
Benzinga Newsdesk 6 months ago
News
FMC Corporation (NYSE:FMC) is making strong progress on its 2026 operational priorities, which are strengthening the balance sheet through targeted debt reduction of approximately $1 billion, improving the
FMC Corporation (NYSE:FMC) is making strong progress on its 2026 operational priorities, which are strengthening the balance sheet through targeted debt reduction of approximately $1 billion, improving the competitiveness of its core portfolio, managing the post-patent transition for Rynaxypyr® active, and driving growth of new active ingredients including Isoflex® active, fluindapyr and Dodhylex® active. In parallel, the Board-authorized evaluation of strategic alternatives announced in February 2026 is progressing, and multiple options are being evaluated.
